Skip to content
HowShorted

Medifast, Inc. short interest in 2024

In 2024, Medifast, Inc.'s disclosed short interest ran from 16.44% of shares outstanding on 12 Jan 2024 to 12.75% on 31 Dec 2024, a change of -3.69 percentage points. The year's high was 31.61% on 14 Jun 2024 and its low 12.75% on 31 Dec 2024, averaging 20.87% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.96 days on 31 Oct 2024. Full history: Medifast, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Medifast, Inc. in 2024

2024 in figures

Start of year
16.44% (12 Jan 2024)
End of year
12.75% (31 Dec 2024)
Change
-3.69 pp
High
31.61% (14 Jun 2024)
Low
12.75% (31 Dec 2024)
Average
20.87%
Highest days to cover
11.96 (31 Oct 2024)
SEC filings marked
8

Every report in 2024

Medifast, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 202416.44%6.22
31 Jan 202417.59%5.23
15 Feb 202417.36%8.56
29 Feb 202417.78%3.4710-K filed, results (8-K)
15 Mar 202418.81%3.98
28 Mar 202424.43%6.60
15 Apr 202427.43%8.53
30 Apr 202428.51%6.2910-Q filed, results (8-K)
15 May 202429.62%6.34
31 May 202431.47%7.11
14 Jun 202431.61%5.69
28 Jun 202426.88%2.50
15 Jul 202427.04%8.55
31 Jul 202425.28%7.58
15 Aug 202419.84%5.6110-Q filed, results (8-K)
30 Aug 202418.95%8.51
13 Sep 202418.75%10.47
30 Sep 202416.81%9.36
15 Oct 202416.15%10.76
31 Oct 202415.12%11.96
15 Nov 202414.59%6.8110-Q filed, results (8-K)
29 Nov 202414.82%8.18
13 Dec 202412.90%5.50
31 Dec 202412.75%5.36

See also: Medifast, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.